|
|
Other links at Articles > Allergy and Clinical Immunology |
| 1. |
NY Course 2008: HIV Resistance Issues
|
|
|
Drs. Mark A. Wainberg and Daniel R. Kuritzkes guide clinicians through antiretroviral drug resistance testing and the latest data on resistance to new antiretroviral classes and novel therapeutics. Medscape HIV/AIDS
|
| 4. |
FDA Safety Changes: Levaquin, Nexavar, AndroGel
|
|
|
The FDA has approved revisions to the safety labeling for oral and injectable levofloxacin (Levaquin), sorafenib tosylate tablets (Nexavar), and testosterone 1% gel (AndroGel). Medscape Medical News
|
|
|